Anti-hyperglycemic activity of Rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines, antioxidants and lipid biomarkers.
Indian J Exp Biol
;
2014 Jul; 52(7): 720-727
Article
Dans Anglais
| IMSEAR
| ID: sea-153752
ABSTRACT
Administration of rutin (50 and 100 mg/kg) and pioglitazone (10 mg/kg) orally for 3 weeks treatment significantly improved body weight, reduced plasma glucose and glycosylated hemoglobin, pro-inflammatory cytokines (IL-6 and TNF-α), restored the depleted liver antioxidant status and serum lipid profile in high fat diet + streptozotocin induced type 2 diabetic rats. Rutin treatment also improved histo-architecture of ß islets and reversed hypertrophy of hepatocytes. Rutin exhibited significant antidiabetic activity, presumably by inhibiting inflammatory cytokines, improving antioxidant and plasma lipid profiles in High fat diet + streptozotocin induced type 2 diabetic model and may be useful as a diabetic modulator along with standard antidiabetic drugs. However, such effects need to be confirmed on human subjects in clinical condition.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Rutoside
/
Glycémie
/
Poids
/
Femelle
/
Mâle
/
Hémoglobine glyquée
/
Marqueurs biologiques
/
Interleukine-6
/
Facteur de nécrose tumorale alpha
/
Rat Sprague-Dawley
Type d'étude:
Étude pronostique
langue:
Anglais
Texte intégral:
Indian J Exp Biol
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS